ArticleEmerging infectious diseases2014
Burkholderia pseudomallei isolates in 2 pet iguanas, California, USA.
Article in Emerging infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Global dispersal of Burkholderia pseudomallei and the evolving endemicity of melioidosis in the United States of America.PLoS neglected tropical diseases · 2026Review
- Postexposure Antimicrobial Drug Therapy in Goats Infected with Burkholderia pseudomallei.Emerging infectious diseases · 2025Article
- Risk Assessment of Global Animal Melioidosis Under Current and Future Climate Scenarios.Animals : an open access journal from MDPI · 2025Article
- Comparison of homologous and heterologous vaccination strategies for combating disease caused byFrontiers in immunology · 2025Article
- The Evolving Global Epidemiology of Human Melioidosis: A Narrative Review.Pathogens (Basel, Switzerland) · 2024Review
- Integrating planetary health education into tertiary curricula: a practical toolbox for implementation.Frontiers in medicine · 2024Article
- Melioidosis in Cynomolgus Macaques (Comparative medicine · 2022Article
- Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change.Current opinion in infectious diseases · 2022Review
- Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray.The New England journal of medicine · 2022Article
- Layered and integrated medical countermeasures againstFrontiers in microbiology · 2022Article
- Genomic Diversity of Burkholderia pseudomallei Isolates, Colombia.Emerging infectious diseases · 2021Article
- Phylogenetic Diversity ofVeterinary and animal science · 2018Article
- Isolation of Burkholderia pseudomallei from a Pet Green Iguana, Belgium.Emerging infectious diseases · 2018Article
- Public health response to an imported case of canine melioidosis.Zoonoses and public health · 2018Article
- Phylogeography of Burkholderia pseudomallei Isolates, Western Hemisphere.Emerging infectious diseases · 2017Article
- Complete Genome Sequence of aGenome announcements · 2017Article
- Article
- The melioidosis agent Burkholderia pseudomallei and related opportunistic pathogens detected in faecal matter of wildlife and livestock in northern Australia.Epidemiology and infection · 2016Article
- A Review of Melioidosis Cases in the Americas.The American journal of tropical medicine and hygiene · 2015Review
- Melioidosis diagnostic workshop, 2013.Emerging infectious diseases · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Burkholderia pseudomallei, the causative agent of melioidosis, was isolated from abscesses of 2 pet green iguanas in California, USA. The international trade in iguanas may contribute to importation of this pathogen into countries where it is not endemic and put persons exposed to these animals at risk for infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.